|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/47 | |
| C07K 19/00 | |||
| A61K 38/17 | |||
| A61P 25/00 | |||
| A61P 35/00 |
| (11) | Number of the document | 2621945 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11833072.9 |
| Date of filing the European patent application | 2011-09-28 | |
| (97) | Date of publication of the European application | 2013-08-07 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/053764 |
| Date | 2011-09-28 |
| (87) | Number | WO 2012/050921 |
| Date | 2012-04-19 |
| (30) | Number | Date | Country code |
| 387439 P | 2010-09-28 | US |
| (72) |
TYMIANSKI, Michael, CA
LI, Rongwen, CA
GARMAN, Jonathan David, CA
|
| (73) |
NoNO Inc.,
88 Strath Avenue, Toronto ON M8X 1R5,
CA
|
| (54) | ND2 PEPTIDES AND METHODS OF TREATING NEUROLOGICAL DISEASE |
| ND2 PEPTIDES AND METHODS OF TREATING NEUROLOGICAL DISEASE |